178 related articles for article (PubMed ID: 38511244)
21. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
[TBL] [Abstract][Full Text] [Related]
22. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis.
Raz-Pasteur A; Shasha D; Paul M
Int J Antimicrob Agents; 2015 Sep; 46(3):242-8. PubMed ID: 26092096
[TBL] [Abstract][Full Text] [Related]
23. Beta-lactam versus beta- lactam/macrolide therapy in pediatric outpatient pneumonia.
Ambroggio L; Test M; Metlay JP; Graf TR; Blosky MA; Macaluso M; Shah SS
Pediatr Pulmonol; 2016 May; 51(5):541-8. PubMed ID: 26367389
[TBL] [Abstract][Full Text] [Related]
24. Trend of Antibiotic Usage for Hospitalized Community-acquired Pneumonia Cases in Korea Based on the 2010-2015 National Health Insurance Data.
Kim B; Myung R; Lee MJ; Kim J; Pai H
J Korean Med Sci; 2020 Dec; 35(47):e390. PubMed ID: 33289366
[TBL] [Abstract][Full Text] [Related]
25. Elderly patients with community-acquired pneumonia: optimal treatment strategies.
Thiem U; Heppner HJ; Pientka L
Drugs Aging; 2011 Jul; 28(7):519-37. PubMed ID: 21721597
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial therapy of community-acquired pneumonia during stewardship efforts and a coronavirus pandemic: an observational study.
Waagsbø B; Tranung M; Damås JK; Heggelund L
BMC Pulm Med; 2022 Oct; 22(1):379. PubMed ID: 36242006
[TBL] [Abstract][Full Text] [Related]
27. Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia.
Donà D; Zingarella S; Gastaldi A; Lundin R; Perilongo G; Frigo AC; Hamdy RF; Zaoutis T; Da Dalt L; Giaquinto C
PLoS One; 2018; 13(2):e0193581. PubMed ID: 29489898
[TBL] [Abstract][Full Text] [Related]
28. No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia.
Wei J; Uppal A; Nganjimi C; Warr H; Ibrahim Y; Gu Q; Yuan H; Rahman NM; Jones N; Walker AS; Eyre DW
J Infect; 2024 Jun; 88(6):106161. PubMed ID: 38663754
[TBL] [Abstract][Full Text] [Related]
29. Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial.
Schweitzer VA; van Heijl I; Boersma WG; Rozemeijer W; Verduin K; Grootenboers MJ; Sankatsing SUC; van der Bij AK; de Bruijn W; Ammerlaan HSM; Overdevest I; Roorda-van der Vegt JMM; Engel-Dettmers EM; Ayuketah-Ekokobe FE; Haeseker MB; Dorigo-Zetsma JW; van der Linden PD; Boel CHE; Oosterheert JJ; van Werkhoven CH; Bonten MJM;
Lancet Infect Dis; 2022 Feb; 22(2):274-283. PubMed ID: 34627499
[TBL] [Abstract][Full Text] [Related]
30. Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia.
Lodise TP; Kwa A; Cosler L; Gupta R; Smith RP
Antimicrob Agents Chemother; 2007 Nov; 51(11):3977-82. PubMed ID: 17709460
[TBL] [Abstract][Full Text] [Related]
31. Antibiotics for community-acquired pneumonia in adult outpatients.
Pakhale S; Mulpuru S; Verheij TJ; Kochen MM; Rohde GG; Bjerre LM
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD002109. PubMed ID: 25300166
[TBL] [Abstract][Full Text] [Related]
32. Retrospective cohort analysis of outpatient antibiotic prescribing for community-acquired pneumonia in Canadian older adults.
Saatchi A; Reid JN; Shariff SZ; Povitz M; Silverman M; Patrick DM; Morris AM; McCormack J; Haverkate MR; Marra F
PLoS One; 2023; 18(10):e0292899. PubMed ID: 37831711
[TBL] [Abstract][Full Text] [Related]
33. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia.
Gleason PP; Kapoor WN; Stone RA; Lave JR; Obrosky DS; Schulz R; Singer DE; Coley CM; Marrie TJ; Fine MJ
JAMA; 1997 Jul; 278(1):32-9. PubMed ID: 9207335
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic treatment outcomes in community-acquired pneumonia.
Çilli A; Sayıner A; Çelenk B; Şakar Coşkun A; Kılınç O; Hazar A; Aktaş Samur A; Taşbakan S; Waterer GW; Havlucu Y; Kılıç Ö; Tokgöz F; Bilge U
Turk J Med Sci; 2018 Aug; 48(4):730-736. PubMed ID: 30119147
[TBL] [Abstract][Full Text] [Related]
35. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
Postma DF; Spitoni C; van Werkhoven CH; van Elden LJR; Oosterheert JJ; Bonten MJM
BMC Infect Dis; 2019 Jan; 19(1):17. PubMed ID: 30612559
[TBL] [Abstract][Full Text] [Related]
36. Association of fluoroquinolones or cephalosporin plus macrolide with
Patel P; Deshpande A; Yu PC; Imrey PB; Lindenauer PK; Zilberberg MD; Haessler S; Rothberg MB
Infect Control Hosp Epidemiol; 2023 Jan; 44(1):47-54. PubMed ID: 35440348
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for drug-resistant Streptococcus pneumoniae and antibiotic prescribing practices in outpatient community-acquired pneumonia.
Jenkins TC; Sakai J; Knepper BC; Swartwood CJ; Haukoos JS; Long JA; Price CS; Burman WJ
Acad Emerg Med; 2012 Jun; 19(6):703-6. PubMed ID: 22632455
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic treatment strategies for community-acquired pneumonia in adults.
Postma DF; van Werkhoven CH; van Elden LJ; Thijsen SF; Hoepelman AI; Kluytmans JA; Boersma WG; Compaijen CJ; van der Wall E; Prins JM; Oosterheert JJ; Bonten MJ;
N Engl J Med; 2015 Apr; 372(14):1312-23. PubMed ID: 25830421
[TBL] [Abstract][Full Text] [Related]
39. Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994-2007.
Kronman MP; Hersh AL; Feng R; Huang YS; Lee GE; Shah SS
Pediatrics; 2011 Mar; 127(3):411-8. PubMed ID: 21321038
[TBL] [Abstract][Full Text] [Related]
40. Comparative Effectiveness of First-Line and Alternative Antibiotic Regimens in Hospitalized Patients With Nonsevere Community-Acquired Pneumonia: A Multicenter Retrospective Cohort Study.
Bai AD; Srivastava S; Wong BKC; Digby GC; Razak F; Verma AA
Chest; 2024 Jan; 165(1):68-78. PubMed ID: 37574164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
